ConductScience.org, home

Paper47018

Is low-renin hypertension a stage in the development of essential hypertension or a diagnostic entity?

Padfield PL and 7 others. Lancet, 1975. Cited by 109 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Is low-renin hypertension a stage in the development of essential hypertension or a diagnostic entity? Papers, record 47018. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/47018

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Is low-renin hypertension a stage in the development of essential hypertension or a diagnostic entity?
PubMed
Journal
Lancet
PubMed
Year
1975
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
109
iCite
Relative citation ratio, by iCite
4.59
iCite
Revised in PubMed
2019-06-10
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Padfield PLP L
2Brown JJJ J
3Lever AFA F
4Schalekamp MAM A
5Beevers DGD G
6Davies DLD L
7Robertson JIJ I
8Tree MM

Source PubMed

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HypertensionMajor topic
ReninMajor topic
Adult
Age Factors
Aged
Aldosterone
Blood Pressure
Blood Specimen Collection
Female
Humans
Hypokalemia
Male
Middle Aged
Photometry
Potassium
Sodium

Source PubMed

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 109 citations.

PMIDTitleJournalYearIn PapersSource
22,832,907Antihypertensives for combating dementia? A perspective on candidate molecular mechanisms and population-based prevention.Transl Psychiatry2012https://conductscience.org/library/papers/22832907PubMed
22,493,079TASK-3 channel deletion in mice recapitulates low-renin essential hypertension.Hypertension2012https://conductscience.org/library/papers/22493079PubMed
20,091,458Progress in primary aldosteronism: present challenges and perspectives.Horm Metab Res2010https://conductscience.org/library/papers/20091458PubMed
11,896,504Primary aldosteronism, a common entity? the myth persists.J Hum Hypertens2002https://conductscience.org/library/papers/11896504PubMed
6,993,778Evidence for a subgroup of essential hypertensives with non-suppressible excretion of aldosterone during sodium loading.Klin Wochenschr1980https://conductscience.org/library/papers/6993778PubMed
2,954,611Plasma atrial natriuretic factor concentrations in essential and renovascular hypertension.Br Med J (Clin Res Ed)1987https://conductscience.org/library/papers/2954611PubMed
1,276,834Immediate plasma renin response to propranolol: differentiation between essential and renal hypertension.Br Med J1976https://conductscience.org/library/papers/1276834PubMed
955,006Deficiency in renomedullary prostaglandin synthesis related to the evolution of essential hypertension.Experientia1976https://conductscience.org/library/papers/955006PubMed
837,134Angiotensin II in essential hypertension.Br Med J1977https://conductscience.org/library/papers/837134PubMed
766,908Spironolactone in essential hypertension: evidence against its effect through mineralocorticoid antagonism.Br Med J1976https://conductscience.org/library/papers/766908PubMed
598,414Failure of methyclothiazide to lower home blood pressure level in "essential" hypertensive and normotensive young men, despite significant plasma volume contraction.Eur J Clin Pharmacol1977https://conductscience.org/library/papers/598414PubMed
510,240Age as a function in the development of sodium-related hypertension.Environ Health Perspect1979https://conductscience.org/library/papers/510240PubMed
449,254Age- and sex-related differences in plasma aldosterone in essential hypertension. Relationship to plasma renin activity.Klin Wochenschr1979https://conductscience.org/library/papers/449254PubMed
366,278The renin-angiotensin-aldosterone system. Past, present and future.Klin Wochenschr1978https://conductscience.org/library/papers/366278PubMed
359,018Acebutolol in hypertension--double-blind trial against placebo.Br J Clin Pharmacol1978https://conductscience.org/library/papers/359018PubMed
9,962Renin and beta-adenoceptor blockade-the mechanism of the hypotensive effect?Br J Clin Pharmacol1976https://conductscience.org/library/papers/9962PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
REN5,972PubTator's text mininghttps://conductscience.org/library/genes/5972

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/47018

GET https://conductscience.org/api/papers/v1/47018/authors